Failure of the Anti-Inflammatory Parasitic Worm Product ES-62 to Provide Protection in Mouse Models of Type I Diabetes, Multiple Sclerosis, and Inflammatory Bowel Disease

Parasitic helminths and their isolated secreted products show promise as novel treatments for allergic and autoimmune conditions in humans. Foremost amongst the secreted products is ES-62, a glycoprotein derived from Acanthocheilonema viteae, a filarial nematode parasite of gerbils, which is anti-inflammatory by virtue of covalently-attached phosphorylcholine (PC) moieties. ES-62 has been found to protect against disease in mouse models of rheumatoid arthritis, systemic lupus erythematosus, and airway hyper-responsiveness. Furthermore, novel PC-based synthetic small molecule analogues (SMAs) of ES-62 have recently been demonstrated to show similar anti-inflammatory properties to the parent molecule. In spite of these successes, we now show that ES-62 and its SMAs are unable to provide protection in mouse models of certain autoimmune conditions where other helminth species or their secreted products can prevent disease development, namely type I diabetes, multiple sclerosis and inflammatory bowel disease. We speculate on the reasons underlying ES-62’s failures in these conditions and how the negative data generated may help us to further understand ES-62’s mechanism of action.

[1]  Liping Zhao,et al.  Initial gut microbiota structure affects sensitivity to DSS-induced colitis in a mouse model , 2018, Science China Life Sciences.

[2]  M. Harnett,et al.  Protection Against Arthritis by the Parasitic Worm Product ES-62, and Its Drug-Like Small Molecule Analogues, Is Associated With Inhibition of Osteoclastogenesis , 2018, Front. Immunol..

[3]  M. Harnett,et al.  Small Molecule Analogues of the parasitic worm product ES-62 interact with the TIR domain of MyD88 to inhibit pro-inflammatory signalling , 2018, Scientific Reports.

[4]  J. Clemente,et al.  The role of the gut microbiome in systemic inflammatory disease , 2018, British Medical Journal.

[5]  M. Harnett,et al.  Dendritic cells provide a therapeutic target for synthetic small molecule analogues of the parasitic worm product, ES-62 , 2017, Scientific Reports.

[6]  Gregory F. Sonnenberg,et al.  Host-Microbiota Interactions Shape Local and Systemic Inflammatory Diseases , 2017, The Journal of Immunology.

[7]  Avijit Ray,et al.  Mechanisms of Regulatory B cell Function in Autoimmune and Inflammatory Diseases beyond IL-10 , 2017, Journal of clinical medicine.

[8]  M. Harnett,et al.  The helminth product, ES-62 modulates dendritic cell responses by inducing the selective autophagolysosomal degradation of TLR-transducers, as exemplified by PKCδ , 2016, Scientific Reports.

[9]  R. Maizels,et al.  Regulation of the host immune system by helminth parasites , 2016, The Journal of allergy and clinical immunology.

[10]  S. Abramson,et al.  The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions , 2016, Nature Reviews Rheumatology.

[11]  M. Harnett,et al.  Testing small molecule analogues of the Acanthocheilonema viteae immunomodulator ES‐62 against clinically relevant allergens , 2016, Parasite immunology.

[12]  P. Howarth,et al.  Microbes and asthma: Opportunities for intervention. , 2016, The Journal of allergy and clinical immunology.

[13]  A. Müller,et al.  The Gastrointestinal Tract Microbiota and Allergic Diseases , 2016, Digestive Diseases.

[14]  M. Harnett,et al.  The parasitic worm-derived immunomodulator, ES-62 and its drug-like small molecule analogues exhibit therapeutic potential in a model of chronic asthma , 2016, Scientific Reports.

[15]  S. Mazmanian,et al.  Gut biogeography of the bacterial microbiota , 2015, Nature Reviews Microbiology.

[16]  P. Volchkov,et al.  Microbiota regulates type 1 diabetes through Toll-like receptors , 2015, Proceedings of the National Academy of Sciences.

[17]  M. Harnett,et al.  Prophylactic and therapeutic treatment with a synthetic analogue of a parasitic worm product prevents experimental arthritis and inhibits IL-1β production via NRF2-mediated counter-regulation of the inflammasome , 2015, Journal of autoimmunity.

[18]  E. Hasby,et al.  FoxP3+ T regulatory cells and immunomodulation after Schistosoma mansoni egg antigen immunization in experimental model of inflammatory bowel disease. , 2015, Cellular immunology.

[19]  M. Harnett,et al.  The Parasitic Worm Product ES-62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice , 2015, Arthritis & rheumatology.

[20]  M. Harnett,et al.  Protective effect of small molecule analogues of the Acanthocheilonema viteae secreted product ES-62 on oxazolone-induced ear inflammation , 2015, Experimental parasitology.

[21]  S. Givan,et al.  Effects of Vendor and Genetic Background on the Composition of the Fecal Microbiota of Inbred Mice , 2015, PloS one.

[22]  Simon A. Jones,et al.  Regulatory B cells are induced by gut microbiota–driven interleukin-1β and interleukin-6 production , 2014, Nature Medicine.

[23]  M. Harnett,et al.  Small molecule analogues of the immunomodulatory parasitic helminth product ES-62 have anti-allergy properties , 2014, International journal for parasitology.

[24]  M. Harnett,et al.  ES‐62 Protects Against Collagen‐Induced Arthritis by Resetting Interleukin‐22 Toward Resolution of Inflammation in the Joints , 2014, Arthritis & rheumatology.

[25]  M. Harnett,et al.  ES-62, a therapeutic anti-inflammatory agent evolved by the filarial nematode Acanthocheilonema viteae. , 2014, Molecular and biochemical parasitology.

[26]  M. Harnett,et al.  Protection against collagen-induced arthritis in mice afforded by the parasitic worm product, ES-62, is associated with restoration of the levels of interleukin-10-producing B cells and reduced plasma cell infiltration of the joints , 2014, Immunology.

[27]  J. Dalton,et al.  Secreted Proteins from the Helminth Fasciola hepatica Inhibit the Initiation of Autoreactive T Cell Responses and Prevent Diabetes in the NOD Mouse , 2014, PloS one.

[28]  Fraser J. Scott,et al.  Designing Anti-inflammatory Drugs from Parasitic Worms: A Synthetic Small Molecule Analogue of the Acanthocheilonema viteae Product ES-62 Prevents Development of Collagen-Induced Arthritis , 2013, Journal of medicinal chemistry.

[29]  J. Weinstock,et al.  Heligmosomoides polygyrus bakeri Infection Activates Colonic Foxp3+ T Cells Enhancing Their Capacity To Prevent Colitis , 2013, The Journal of Immunology.

[30]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[31]  A. Loukas,et al.  Hookworm Excretory/Secretory Products Induce Interleukin-4 (IL-4)+ IL-10+ CD4+ T Cell Responses and Suppress Pathology in a Mouse Model of Colitis , 2013, Infection and Immunity.

[32]  M. Harnett,et al.  The helminth product, ES-62, protects against airway inflammation by resetting the Th cell phenotype , 2013, International journal for parasitology.

[33]  M. Harnett,et al.  Mast Cell Subsets and Their Functional Modulation by the Acanthocheilonema viteae Product ES-62 , 2013, Journal of parasitology research.

[34]  M. Harnett,et al.  The parasitic helminth product ES-62 suppresses pathogenesis in collagen-induced arthritis by targeting the interleukin-17-producing cellular network at multiple sites. , 2012, Arthritis and rheumatism.

[35]  M. Doligalska,et al.  Heligmosomoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes. , 2012, Experimental parasitology.

[36]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[37]  Christophe Benoist,et al.  Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. , 2010, Immunity.

[38]  D. Kasper,et al.  A polysaccharide from the human commensal Bacteroides fragilis protects against CNS demyelinating disease , 2010, Mucosal Immunology.

[39]  J. Rhee,et al.  Generation of regulatory dendritic cells and CD4+Foxp3+ T cells by probiotics administration suppresses immune disorders , 2010, Proceedings of the National Academy of Sciences.

[40]  L. Boon,et al.  Infection with a Helminth Parasite Attenuates Autoimmunity through TGF-β-Mediated Suppression of Th17 and Th1 Responses1 , 2009, The Journal of Immunology.

[41]  M. Hübner,et al.  Inhibition of type 1 diabetes in filaria‐infected non‐obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells , 2009, Immunology.

[42]  A. Cooke,et al.  Schistosoma mansoni egg antigens induce Treg that participate in diabetes prevention in NOD mice , 2009, European journal of immunology.

[43]  S. Targan,et al.  TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. , 2008, Gastroenterology.

[44]  Zhengqi Lu,et al.  Soluble egg antigen from Schistosoma japonicum modulates the progression of chronic progressive experimental autoimmune encephalomyelitis via Th2-shift response , 2008, Journal of Neuroimmunology.

[45]  O. Kämpe,et al.  Unexpected regulatory roles of TLR4 and TLR9 in experimental autoimmune encephalomyelitis , 2008, European journal of immunology.

[46]  M. Neurath,et al.  Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue , 2007, Nature Protocols.

[47]  R. Maizels,et al.  Expansion and activation of CD4+CD25+ regulatory T cells in Heligmosomoides polygyrus infection , 2007, European journal of immunology.

[48]  A. Cooke,et al.  Salmonella typhimurium infection halts development of type 1 diabetes in NOD mice , 2004, European journal of immunology.

[49]  M. Harnett,et al.  Hyporesponsiveness of murine B lymphocytes exposed to the filarial nematode secreted product ES‐62 in vivo , 2003, Immunology.

[50]  A. Cooke,et al.  Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes , 2003, European journal of immunology.

[51]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[52]  M. Harnett,et al.  The Parasitic Worm Product ES-62 , 2015 .

[53]  W. Harnett,et al.  Can the Study of Helminths Be Fruitful for Human Diseases , 2014 .

[54]  R. Maizels,et al.  Helminth-induced CD 19 1 CD 23 hi B cells modulate experimental allergic and autoimmune inflammation , 2010 .

[55]  E. Reinke,et al.  Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. , 2003, International immunology.